Loring Wolcott & Coolidge Fiduciary Advisors’s Express Scripts Holding Company ESRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ESRX
ECM
BJL
BSPF
MYAM
AWM
W
ACA
UCFA
SBL
Loring Wolcott & Coolidge Fiduciary Advisors's ESRX Position: Q4 2018 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 440 shares — an estimated $42K sold.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $970K in Q1 2014. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 440 Express Scripts Holding Company shares in Q4 2018, an estimated $42K.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's Express Scripts Holding Company position peaked at $970K in Q1 2014.
- 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.